Diagnosis of Cystic Endocrine Tumors of the Pancreas. Differential Possibilities of Application of Radiation Methods (Case Report)
https://doi.org/10.24835/1607-0763-2017-3-105-111
Abstract
Nonfunctioning neuroendocrine tumors (NFET) account for up to 33% of the neuroendocrine tumors of the pancreas, ranging from 1 to20 cmin diameter and showing a higher malignancy rate, up to 90%. The clinical presentation of nonfunctioning neuroendocrine tumors is nonspecific. These tumors, in fact, are predominantly characterized by an expansive growth pattern; therefore, they are clinically silent until adjacent viscera and structures are involved. This makes it difficult to diagnose NFET at an early stage. Correct diagnosis is typically delayed by several years. About 15% of pancreatic NFET are cystic and difficult to differentiation from other cystic pancreatic lesions. In such cases, the important role played by hypervascular rim in the arterial phase image. Literature review and case report оf diagnostics and treatment of Neuroendocrine Tumor with cystic transformation are presented in the article.
About the Authors
V. M. DurleshterRussian Federation
Vladimir M. Durleshter – doct. of med. sci, professor, deputy chief doctor of surgery of “Regional clinical hospital №2”, Krasnodar, head of the Department of Surgery №3 of Kuban State Medical University
S. R. Genrykh
Russian Federation
Stanislav R. Genrykh – doct. of med. sci., deputy chief doctor of surgery
Contact: Stanislav R. Genrykh – Bakanskaya str., 28/6, Krasnodar, 350038.
E. N. Karanadze
Russian Federation
Competing Interests: Elena N. Karanadze – cand. of med. sci., head of radiology department of Regional clinical hospital №2, Krasnodar, assistent of department of radiology of Kuban State Medical University
A. V. Andreev
Russian Federation
Andrey V. Andreev – doct. of med. sci, head of Department of X-ray Surgery and Ultrasound methods of Diagnostics and Treatment of Regional clinical hospital №2, Krasnodar, Professor оf Department of Surgery №3 of Kuban State Medical University an>
R. V. Gedzun
Russian Federation
Roman V. Gedzun – cand. of med. sci., surgeon of a Surgery Department №1
N. N. Kuzmenko
Russian Federation
Nikolay N. Kuzmenko – radiologist of Radiology Department
References
1. Kosmahl M., Pauser U., Peters K., Sipos B., Lüttges J., Kremer B., Klöppel G. Cystic neoplasms of the pancreas and tumor-like lesions with cystic features: a review of 418 cases and a classification proposal. Virchows Arch. 2004; 445: 168–178.
2. Stamatakos M., Sargedi C., Angelousi A. Management of rare entity of primary pancreatic cystic neoplasms. J. Gastroenterol. Hepatol. 2009; 24: 1203–1210. DOI: 10.1111/j.1440-1746.2009.05855.x.
3. Степанова Ю.А., Дубова Е.А., Кармазановский Г.Г., Сидорова Е.Е., Икрамов Р.З. Лучевая диагностика нейро эндокринных опухолей поджелудочной железы с кистозной трансформацией структуры. Медицинская визуализация. 2009; 4: 98–109. Stepanova Yu.A., Dubova E.A., Karmazanovsky G.G., Sidorova E.E., Ikramov R.Z. Radiology diagnosis of neuroendocrine tumors of the pancreas with cystic transformation of the structure. Medical Visualization. 2009; 4: 98–109. (In Russian)
4. Kartalis N., Mucelli R.M.P., Sundin A. Recent developments in imaging of pancreatic neuroendocrine tumors. Ann. Gastoenterol. 2015; 28: 193–202.
5. Holzapfel K., Fingerle A., Rummeny E. Aktueller Stand der bildgebenden Diagnostik des Pankreaskarzinoms. Onkologe. 2010; 16: 568–579. DOI: 10.1007/s00761010-1847-1.
6. Fernandez-del Castillo C., Targarona J., Thayer S.P., Rattner D.W., Brugge W.R., Warshaw A.L. Incidental pancreatic cysts: clinicopathologic characteristics and comparison with symptomatic patients. Arch. Surg. 2003; 138: 427–423; discussion, 423–424.
7. Kim Y.C., Choi J.Y., Chung Y.E., Bang S., Kim M.J., Park M.S., Kim K.W. Comparison of MRI and endoscopic ultrasound in characterization of pancreatic cystic lesion. Am. J. Roentgenol. 2010; 195: 947–952. DOI: 10.2214/AJR.09.3985.
8. Brugge W.R., Lewandrowski K., Lee-Lewandrowski E., Centeno B.A., Szydlo T., Regan S., del Castillo C.F., Warshaw A.L. Diagnostic of pancreatic cystic neoplasm: a report of the cooperative pancreatic cyst study. Gastroenterology. 2004; 126: 1330–1336.
9. Sahani D.V., Kambadakone A., Macari M., Takahashi N., Chari S., Fernandez-del Castillo C. Diagnosis and management of cystic pancreatic lesions. Am. J. Roentgenol. 2013; 200 (2): 343–354. DOI: 10.2214/AJR.12.8862.
10. Rickes S., Unkrodt K., Ocran K., Neye H., Wermke W.. Differentiation of neuroendocrine tumors from other pancreatic lesions by echo-enhanced power Doppler sonography and somatostatin receptor scintigraphy. Pancreas. 2003; 26: 76–81.
11. Kitano M., Kudo M., Maekawa K., Suetomi Y., Sakamoto H., Fukuta N., Nakaoka R., Kawasaki T. Dynamic imaging of pancreatic diseases by contrast enhanced coded phase inversion harmonic ultrasonography. Gut. 2004; 53: 854–859.
12. Grützman R., Post S., Detlev Saeger H., Niedergethmann M. Intraductal papillary-mucinous Neoplasia of the pancreas. Dtsch. Arztebl. Int. 2011; 108 (46): 788–794; DOI: 10.3238/arztebl.2011.0788.
13. Morgan D.E., Baron T.H., Smith J.K., Robbin M.L., Kenney P.J. Pancreatic flued collections prior to intervention with MRI compared with CT and US. Radiology. 1997; 203: 773–778.
14. Waters J.A., Schmidt C.M., Pinchot J.W. et al. CT vs MRCP: optimal classification of IPMN type and extent. J. Gastrointest. Surg. 2008; 12: 101–109.
15. Lauenstein T.C., Sharma P., Hunges T., Heberlein K., Tudorascu D., Martin D.R. Evaluation of optimized inversion-recovery fat-suppression techniques for T2weighted abdominal MR imaging. J. Magn. Reson. Imaging. 2008; 27: 1448–1454. DOI: 10.1002/jmri.21350.
16. Sureka B., Bihari C., Arora A., Agrawal N., Bharathy K.G.S. Imaging Paradigm of Cystic Lesions in Pancreas. J. Pancreas. 2016; 17 (5): 452–465.
17. Malleo G., Bassi C., Rossini R., Manfredi R., Butturini G., Massignani M., Paini M., Pederzoli P., Salvia R. Growth pattern of serous cystic neoplasms of the pancreas: observational study with long-term magnetic resonance surveillance and recommendations for treatment. Gut. 2012; 61: 746–751. DOI: 10.1136/gutjnl-2011-300297.
18. Crippa S., Fernández-Del Castillo C., Salvia R., Finkelstein D., Bassi C., Domínguez I., Muzikansky A., Thayer S.P., Falconi M., Mino-Kenudson M., Capelli P., Lauwers G.Y., Partelli S., Pederzoli P., Warshaw A.L. Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. Clin. Gastroenterol. Hepatol. 2010; 8: 213–219. DOI: 10.1016/j.cgh.2009.10.001.
19. Cloyd J.M., Poultsides G.A. Non-functional neuroendocrine tumors of the pancreas: Advances in diagnosis and management. Wld J. Gastroenterol. 2015; 21 (32): 9512–9525. DOI: 10.3748/wjg.v21.i32.9512.
20. Bertolotto M., D'Onofrio M., Martone E., Malagò R., Pozzi Mucelli R. Ultrasonography of the pancreas. 3. Doppler imaging. Abdom. Imaging. 2007; 32 (2): 161–170.
Review
For citations:
Durleshter V.M., Genrykh S.R., Karanadze E.N., Andreev A.V., Gedzun R.V., Kuzmenko N.N. Diagnosis of Cystic Endocrine Tumors of the Pancreas. Differential Possibilities of Application of Radiation Methods (Case Report). Medical Visualization. 2017;(3):105-111. (In Russ.) https://doi.org/10.24835/1607-0763-2017-3-105-111